Immune and genomic profiling of small cell carcinomas of the ovary hypercalcemic type by Dessources, K., Holland, A., Liu, J.D., Lee, S.S., Selenica, P., Wu, M., Stylianou, A., Reis-Filho, J., Hyman, D.M., Hollmann, T.J., Zamarin, D., Weigelt, B.

Get full text

Compositional and architectural characterization of high-grade serous ovarian carcinomas using single cell technologies and multiplex microscopy by Kim, S.H., Holland, A., Jimenez-Sanchez, A., Bykov, Y., Fromme, R.M., Stylianou, A., Walther, T., Liu, C., Leitao, M.M., Zivanovic, O., Sonoda, Y., Chi, D.S., Abu-Rustum, N.R., Mazutis, L., Plitas, G., Hollmann, T.J., Weigelt, B., Pe'er, D., Zamarin, D.

Get full text

A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer by Friedman, C.F., Snyder, A., Abu-Rustum, N.R., Broach, V., Brown, C.L., Bykov, Y., Cadoo, K.A., Chi, D.S., Cohen, S., Eid, K.T., Gardner, G.J., Grisham, R.N., Holland, A., Hollmann, T.J., Iasonos, A., Leitao, M.M., Roche, K. Long, O'Cearbhaill, R.E., Tew, W.P., Weissblum, S., Wibmer, A.G., Zhou, Q., Zivanovic, O., Aghajanian, C., Zamarin, D.

Get full text

Contraposition of endotoxin-induced shock in C3A receptor- and C3-deficient mice by Kildsgaard, J., Hollmann, T.J., Matthews, K.W., Drouin, S.M., Haviland, D.L., Wetsel, R.A.

Get full text